Subscribe to Newsletter

Drug Discovery

Discovery & Development Drug Discovery

Rewards in the Real World: Sitting Down With Igor Fisch

| 4 min read

Discussing the development of trends, treatments, and talent in gene therapy with NewBiologix CEO Igor Fisch.

Business & Regulation Profession

The Blood Cancer Success Story: Part 2

| Stephanie Vine | 6 min read

Lore Gruenbaum discusses The Leukemia & Lymphoma Society, advances in blood cancers, and the role of nonprofits.

Discovery & Development Drug Discovery

Three Amazing Medicine Making Stories

| Stephanie Vine | 3 min read

Ivermectin, Viagra and warfarin; I look at the origins of three popular drugs and the role of serendipity.

Discovery & Development Drug Discovery

Hidden Pathways on the Surface of Cells

| Rob Coker | 1 min read

Advances in computer simulations allow researchers to look at G protein-coupled receptors in more detail than ever before.

Discovery & Development Drug Discovery

The Shingles Vaccine and Dementia

| Stephanie Vine | 2 min read

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.

Business & Regulation Profession

The Blood Cancer Success Story: Part 1

| Stephanie Vine | 7 min read

Lore Gruenbaum tells us about her career spanning big pharma, biotech and now The Leukemia & Lymphoma Society.

Discovery & Development Bioprocessing - Upstream & Downstream

Biotech Versus the Superbugs

| 6 min read

Biotech Versus the Superbugs: Interviewing Centauri Therapeutics CSO Helen Bright

Discovery & Development Drug Discovery

Combatting the Side Effects of Treatments for Parkinson’s

| 4 min read

Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.

Discovery & Development Drug Discovery

Antibiotics: Going With the Flow

| Rob Coker | 2 min read

How fluid flow through the body can affect the ways in which antibiotics work.

Discovery & Development Drug Discovery

The Glycomic Revolution

| 2 min read

Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D.


Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register